Tag: Hua Medicine
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China –...
Hua Medicine (Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was...
Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine’s Dorzagliatin Readying for NDA...
Hua Medicine (the "Company", Stock Code: 2552.HK), today announces the audited annual results of the Company and its subsidiaries for the year ended December...
Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
Hua Medicine (the "Company", Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder ("MAH") system, the Company has...
Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of...
Hua Medicine today announced the positive 24-week top-line results from HMM0302, a Phase III registration trial in China of its global first-in-class glucokinase activator...
Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin’s Phase III Monotherapy Trial
Hua Medicine (the "Company", Stock Code: 2552.HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today...
Hua Medicine Announces Positive Results in the Combination Study of Dorzagliatin with Empagliflozin (a...
Hua Medicine (the "Company", Stock Code: 2552. HK) today announces the positive results of the clinical study HMM0112.
HMM0112 is a Phase I trial conducted...
Hua Medicine Announces 2019 Annual Results
Pivotal Phase III Trial Achieved Clinical Efficacy Endpoint at 24 Weeks
Dorzagliatin-Driven Portfolio Expands
Hua Medicine (the "Company", Stock Code on The Stock Exchange of Hong...
Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology...
Hua Medicine, a leading clinical stage biotechnology company based in Shanghai, is pleased to announce that Dr. Fuxing Tang has joined Hua Medicine as...
